|
14 Feb 2008 |
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
|
|
13 Feb 2008 |
Introgen's p53 Immunotherapy INGN 225 Begins Randomized, Controlled Clinical Trial in Patients with Small Cell Lung Cancer
|
|
13 Feb 2008 |
Ophthotech Enrolls Its First Patient in a Phase I Anti-PDGF Macular Degeneration Trial
|
|
09 Feb 2008 |
VGX Pharmaceuticals Announces the IND Filing of VGX-3200, a Novel DNA Therapy That Utilizes GHRH for the Treatment of Cancer Cachexia and Anemia
|
|
07 Feb 2008 |
Alnylam Reports Pre-clinical Progress with RNAi Therapeutics in Neurological Disease
|
|
06 Feb 2008 |
Insception Biosciences Begins Human Clinical Trials of Stem Cell Treatment That Could Replace Bone Marrow Transplants
|
|
30 Jan 2008 |
Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
|
|
29 Jan 2008 |
Topigen Pharmaceuticals Initiates European Phase 2 Clinical Study of TPI ASM8 in Patients with Asthma
|
|
23 Jan 2008 |
Alnylam Reports Positive Phase II Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
|
|
22 Jan 2008 |
MolMed gets regulatory approval to start a Phase III trial in Italy of its TK therapy for high risk acute leukaemia
|
|
18 Jan 2008 |
StemCells, Inc. Provides Batten's Clinical Trial Update
|
|
18 Jan 2008 |
Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
|
|
11 Jan 2008 |
Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
|
|
08 Jan 2008 |
Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization
|
|
08 Jan 2008 |
Tacere Therapeutics Eenters Collaborationa and License Agreement With Pfizer to Develop and Commercilize RNAi Hepatitis C Drug
|
|
07 Jan 2008 |
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
|
|
27 Dec 2007 |
Leiden University Medical Center and Prosensa B.V. Announce New England Journal of Medicine Publication of First Successful Clinical Study with RNA-based Therapeutic PRO051 in Duchenne Muscular Dystrophy
|
|
20 Dec 2007 |
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
|
|
18 Dec 2007 |
Year-end clinical trial update
|
|
18 Dec 2007 |
Epeius Biotechnologies gains commercial approval for Rexin-G(R), a tumor-targeted gene-based medicine for metastatic cancer
|
|
13 Dec 2007 |
Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection
|
|
13 Dec 2007 |
Oxford biomedica initiates Phase I/II trial of prosavin (R) gene-based treatment for parkinson's disease
|
|
12 Dec 2007 |
Gene A/S begins Phase Ib clinical trial with NsG0202 for the treatment of Alzheimer's disease
|
|
12 Dec 2007 |
Ceregene Presents Long-Term Follow-Up from Phase 1 Trial of CERE-120 in Parkinson's Disease
|
|
12 Dec 2007 |
NeuroSearch's associated company NsGene A/S starts Phase Ib clinical study with NsG0202 for the treatment of Alzheimer's disease
|
